Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950005-03-000650
Filing Date
2003-06-03
Accepted
2003-06-03 12:50:24
Documents
2
Group Members
ALIX MARDUELALTA BIO PHARMA MANAGEMENT, LLCALTA BIOPHARMA PARTNERS, L.P.ALTA EMBARCADERO BIOPHARMA, LLCALTA PARTNERSALTA/CHASE BIOPHARMA MANAGMENT, LLCDANIEL JANNEYFLAMEL CHASE PARTNERS (ALTA BIO), LLCGARRETT GRUENERGUY NOHRAJEAN DELEAGE

Document Format Files

Seq Description Document Type Size
1 p17208_sc13da.txt SC 13D/A 50617
3 JOINT FILING STATEMENT p17208_exa.txt EX-99.A 2497
  Complete submission text file 0000950005-03-000650.txt   55538
Mailing Address
Business Address PARC CLUB DU MOULIN A VENT 33 AVE DU DOCTEUR GEORGES LEVY VENISSIEUX CED I0 69693 2126641666
FLAMEL TECHNOLOGIES SA (Subject) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50223 | Film No.: 03729661
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE EMBARCADERO CENTER STE 4050 SAN FRANCISCO CA 94111
Business Address ONE EMBARCADERO CENTER STE 4050 SAN FRANCISCO CA 94111 4153624022
ALTA PARTNERS (Filed by) CIK: 0001060013 (see all company filings)

EIN.: 943238854 | State of Incorp.: CA | Fiscal Year End: 1231